“…The NMDA receptor antagonist 2-amino-5-phosphonovaleric acid (APV, 30 nmol in 10 μl, Sigma, St. Louis, MO, USA) or 5-HT 3 receptor antagonist Y-25130 (30 fmol in 10 ul, Tocris, Bioscience, Bristol, UK ) was then administered at 30 min before CFA injection and each FS. The doses of drugs were determined by previous studies [ 13 , 14 ] and our preliminary experiments. Intrathecal injection of saline was used for vehicle control.…”